$73.00
-0.26[-0.35%]
At close: Apr 26
$73.00
0[0.00%]
After Hours: 4:35PM EDT
Boston Scientific
(NYSE:BSX)Boston Scientific Stock (NYSE:BSX), Analyst Ratings, Price Targets, Predictions
Boston Scientific Corp has a consensus price target of $70.4, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Barclays, Citigroup, and Deutsche Bank on April 26, 2024, April 25, 2024, and April 25, 2024. With an average price target of $78.67 between Barclays, Citigroup, and Deutsche Bank, there's an implied 7.76% upside for Boston Scientific Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Citigroup
Deutsche Bank
JP Morgan
Raymond James
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Boston Scientific
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/26/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 6.85% | Barclays | Matt Miksic | $70 → $78 | Maintains | Overweight | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 16.44% | Citigroup | Joanne Wuensch | $79 → $85 | Maintains | Buy | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | — | Deutsche Bank | Pito Chickering | $63 → $73 | Maintains | Hold | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 12.33% | JP Morgan | Robbie Marcus | $72 → $82 | Maintains | Overweight | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 16.44% | Raymond James | Jayson Bedford | $73 → $85 | Maintains | Strong Buy | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 12.33% | RBC Capital | Shagun Singh | $78 → $82 | Maintains | Outperform | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 16.44% | Mizuho | Anthony Petrone | $80 → $85 | Maintains | Buy | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 23.29% | UBS | Danielle Antalffy | $74 → $90 | Maintains | Buy | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 12.33% | Wells Fargo | Larry Biegelsen | $72 → $82 | Maintains | Overweight | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 6.85% | Evercore ISI Group | Vijay Kumar | $72 → $78 | Maintains | Outperform | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 15.07% | Baird | David Rescott | $79 → $84 | Maintains | Outperform | Get Alert |
| 04/24/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 12.33% | Needham | Mike Matson | $71 → $82 | Maintains | Buy | Get Alert |
| 04/15/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 6.85% | RBC Capital | Shagun Singh | $70 → $78 | Maintains | Outperform | Get Alert |
| 04/04/2024 | BSX | Buy Now | Boston Scientific | $73.00 | -1.37% | Evercore ISI Group | Vijay Kumar | $68 → $72 | Maintains | Outperform | Get Alert |
| 04/03/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 9.59% | Argus Research | John Eade | $69 → $80 | Maintains | Buy | Get Alert |
| 04/03/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 8.22% | Citigroup | Joanne Wuensch | $71 → $79 | Maintains | Buy | Get Alert |
| 03/07/2024 | BSX | Buy Now | Boston Scientific | $73.00 | 5.48% | TD Cowen | Joshua Jennings | $65 → $77 | Maintains | Outperform | Get Alert |
| 02/05/2024 | BSX | Buy Now | Boston Scientific | $73.00 | -4.11% | RBC Capital | Shagun Singh | → $70 | Reiterates | Outperform → Outperform | Get Alert |
| 02/01/2024 | BSX | Buy Now | Boston Scientific | $73.00 | -2.74% | Citigroup | Joanne Wuensch | $65 → $71 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Boston Scientific (BSX)?
The latest price target for Boston Scientific (NYSE: BSX) was reported by Barclays on April 26, 2024. The analyst firm set a price target for $78.00 expecting BSX to rise to within 12 months (a possible 6.85% upside). 68 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Boston Scientific (BSX)?
The latest analyst rating for Boston Scientific (NYSE: BSX) was provided by Barclays, and Boston Scientific maintained their overweight rating.
When was the last upgrade for Boston Scientific (BSX)?
The last upgrade for Boston Scientific Corp happened on February 1, 2024 when Mizuho raised their price target to $80. Mizuho previously had a neutral for Boston Scientific Corp.
When was the last downgrade for Boston Scientific (BSX)?
There is no last downgrade for Boston Scientific.
When is the next analyst rating going to be posted or updated for Boston Scientific (BSX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Boston Scientific, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Boston Scientific was filed on April 26, 2024 so you should expect the next rating to be made available sometime around April 26, 2025.
Is the Analyst Rating Boston Scientific (BSX) correct?
While ratings are subjective and will change, the latest Boston Scientific (BSX) rating was a maintained with a price target of $70.00 to $78.00. The current price Boston Scientific (BSX) is trading at is $73.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.